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Abstract
Autophagic cell death or abortive autophagy has been proposed to eliminate damaged as well as cancer cells, but there
remains a critical gap in our knowledge in how this process is regulated. The goal of this study was to identify modulators of
the autophagic cell death pathway and elucidate their effects on cellular signaling and function. The result of our siRNA
library screenings show that an intact coatomer complex I (COPI) is obligatory for productive autophagy. Depletion of COPI
complex members decreased cell survival and impaired productive autophagy which preceded endoplasmic reticulum
stress. Further, abortive autophagy provoked by COPI depletion significantly altered growth factor signaling in multiple
cancer cell lines. Finally, we show that COPI complex members are overexpressed in an array of cancer cell lines and several
types of cancer tissues as compared to normal cell lines or tissues. In cancer tissues, overexpression of COPI members is
associated with poor prognosis. Our results demonstrate that the coatomer complex is essential for productive autophagy
and cellular survival, and thus inhibition of COPI members may promote cell death of cancer cells when apoptosis is
compromised.
Citation: Claerhout S, Dutta B, Bossuyt W, Zhang F, Nguyen-Charles C, et al. (2012) Abortive Autophagy Induces Endoplasmic Reticulum Stress and Cell Death in
Cancer Cells. PLoS ONE 7(6): e39400. doi:10.1371/journal.pone.0039400
Editor: Gordon Langsley, Institut national de la sante ´ et de la recherche me ´dicale - Institut Cochin, France
Received March 22, 2011; Accepted May 21, 2012; Published June 26, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This research was supported in part by grants from the Komen Foundation (KG 081694 and FAS0703849), the Cancer Prevention and Research Institute
of Texas, and Ovarian Cancer Research Fund to GBM, and by the MD Anderson Cancer Center Support Grant CA016672. SC is supported by the Odyssey Program
and the Theodore N. Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center. JBD is supported by the MD Anderson
GlaxoSmithKline TRIUMPH fellowship program and BD by National Institutes of Health siRNA consortium for therapeutics. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: SAClaerhout@mdanderson.org
¤ Current address: Department of Defense Biotechnology High Performance Computing Software Applications Institute, United States Army Medical Research and
Materiel Command, Frederick, Maryland, United States of America
Introduction
Cancer cells encounter several barriers such as pH changes and
a restricted supply of nutrients and oxygen during cancer
initiation, progression, and dissemination [1]. To reestablish
proper cellular function and homeostasis under low to moderate
levels of stress, cancer cells activate protective cellular processes
such as autophagy. Autophagy is a highly conserved process found
from yeast to mammals. It is a unique degradation process
characterized by the sequestration of bulk cytoplasm including
proteins and organelles, which are delivered to the lysosomal
system for final digestion [2]. Removal and degradation of these
cellular components produces energy and the building blocks
necessary for the survival of cancer cells during metabolic stress.
The completion of this process is designated productive autophagy
or autophagic flux [2]. However, non-productive, uncontrolled, or
prolonged autophagy leads to what has been designated ‘‘autoph-
agic cell death’’ [3,4] or, as we refer to, ‘‘abortive autophagy’’ [5].
In cancer, the process of autophagy has been proposed to
contribute both to tumor suppression and progression. On the one
hand, autophagy suppresses tumors by limiting initiation and
progression. The expression of Beclin 1, the mammalian homolog
of yeast autophagy gene Atg6 which is critical for induction of
autophagy, is decreased in many cancer tissues and cancer cell
lines [6]. In addition, the ultraviolet radiation resistance–associ-
ated gene (UVRAG), necessary for the tumor suppressor function of
Beclin 1, is also monoallelically mutated in many human cancers
[7]. Moreover, autophagy also suppresses tumorigenesis by
providing the ATP required for DNA repair [8] or by eliminating
the long-lived protein p62 [9]. On the other hand, autophagy may
promote tumorigenesis by overcoming the stress evoked by the
lack of nutrients and oxygen in pre-invasive and rapidly growing
tumors. Our lab has shown that the LKB1-AMPK pathway-
dependent phosphorylation of p27 at threonine 198 stabilizes p27
and permits cells to survive growth-factor withdrawal and
metabolic stress by inducing autophagy [10]. This autophagic
response may contribute to tumor-cell survival during growth-
factor deprivation or disrupted nutrient and energy metabolism.
Thus, depending on the cellular context and the strength and
duration of the stress signals, autophagy either prevents or
promotes carcinogenesis.
In addition to its role in carcinogenesis, autophagy also
modulates the efficacy of therapeutic drugs. Induction of a
‘‘productive’’ autophagic process by chemotherapy and radia-
tion permits the survival of cancer cells [11]. This suggests that
autophagy modulators may sensitize tumor cells to conventional
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autophagy, the cells may undergo ‘‘abortive autophagy’’, an
alternative death mechanism for cancer cells resistant to
apoptosis-inducing agents [11,13]. Although the process of
productive autophagy has been studied extensively, it is unclear
which factors regulate abortive autophagy. Identifying these
modulators could improve the efficacy of conventional therapy
and contribute in the discovery of novel treatments for cancer
patients.
The purpose of this study was to identify regulators of abortive
autophagy and elucidate their effect on signaling mechanisms and
cellular survival in cancer cells. We employed small interfering
RNA (siRNA) screens in combination with validation and
functional studies. Members of the coatomer complex I (COPI),
which are involved in cellular trafficking, emerged as top hits from
our screens modulating autophagy and cell death in cancer cells.
Abortive autophagy and endoplasmic reticulum (ER) stress was
observed after knockdown of COPI components. Additionally,
COPI depletion affected phosphoinositide 3-kinase (PI3K)/AKT
signaling pathway. Altogether, the effects of COPI on cell death,
autophagy and ER stress were more pronounced in cancer cells
than in normal cells. This is consistent with the overexpression of
COPI proteins and genes seen in cancer cell lines and patient
samples.
Materials and Methods
Cell Lines and Reagents
The human breast cancer cell lines MDA-MB-231 [10], MDA-
MB-468 [10], BT549 (American Type Culture Collection
(ATCC); Manassas, VA), T47D [10], SKBR3 (ATCC),
HCC1428 (ATCC) and MCF7 [10], the ovarian cancer cell lines
SKOV3 (ATCC), and OVCAR3 (ATCC) were maintained in
RPMI 1640 (Invitrogen, Carlsbad, CA) and 5% FBS. MDA-MB-
231, MDA-MD468, and SKOV3 cells stably transfected with
GFP-LC3 were grown in the same medium. The osteosarcoma
cell line U2OS (ATCC) and U2OS GFP-LC3 [10] were cultured
in DMEM and 10% FBS. MCF10A (ATCC) was cultured in
DMEM/F12 and 5% horse serum with 20 ng/ml EGF, 0.5 mg/
ml hydrocortisone, 100 ng/ml cholera toxin, and 10 mg/ml
insulin. GFP-LC3 stable cell lines were generated as described in
[10]. Cell lines were validated by STR DNA fingerprinting using
the AmpF,STR Identifiler kit according to manufacturer instruc-
tions (Applied Biosystems cat 4322288). The STR profiles were
compared to known ATCC fingerprints (ATCC.org), to the Cell
Line Integrated Molecular Authentication database (CLIMA)
version 0.1.200808 [14] and to the MD Anderson fingerprint
database. Imatinib, a kind gift from Dr. S. Kondo at MD
Anderson Cancer Center, and Bafilomycin A1 (Sigma-Aldrich, St.
Louis, MO) were dissolved in DMSO. Brefeldin A (Sigma-Aldrich)
and rapamycin (Cell Signaling Technology, Beverly, MA) was
dissolved in methanol.
siRNA Screens
Accell siRNA screen for autophagy modulators. MDA-
MB-231, U2OS, and SKOV3 cells stably transfected with GFP-
LC3 were seeded in 96-well plates at 2500 cells/well for MDA-
MB-231 and SKOV3 cells or 1000 cells/well for U2OS cells.
After 24 h medium was changed to Accell medium containing
0.05% FBS (80 ml/well) (Thermo Fisher Scientific, Lafayette,
CO). Accell siRNAs (G-201000 Human RNAi Global, Lot
08103, in 96-well plates) were dissolved in 10 ml of 1x siRNA
buffer and incubated on a shaker at room temperature for
30 min. Accell media (200 ml) containing 0.05% FBS was added
to each well and mixed by pipetting five times. The dissolved
siRNAs (20 ml) were added to each well to make a final siRNA
concentration of 1 mM (100 ml/well). Cells were incubated with
siRNA for 48 h. Drugs were diluted to a ten times working
concentration and added to each well as indicated (11 ml/well)
to make final concentrations of 2 mM 2-Deoxy-D-glucose
(2DG), 100 nM rapamycin, and 10 mM imatinib. Cells were
washed with PBS and fixed with 4% paraformaldehyde in PBS
for 45 min at room temperature. Cells were washed three times
with PBS, nuclei stained with Hoechst 33342 for 5 min and
washed once again with PBS, and 250 ml PBS was added to the
cells. Autophagosome formation was determined by an IN Cell
Analyzer 1000 Cellular Imaging and Analysis system (GE
Healthcare, Piscataway, New Jersey). Results are shown as %
autophagy. In addition, all the genes were combined together
for z-score calculation. Z-score of gene i was calculated from as
zi =( xi – m)/s, where, xi is the % autophagy from the
autophagy screen, and m and s are the mean and standard
deviations based on all genes present in the screen.
siRNA screen for viability modulators. We used an
arrayed library of 779 siRNA pools (http://www.dharmacon.
com/product/Productlandingtemplate.aspx?id=225&tab=1 for
gene list) covering the human kinome and kinase related genes
(Dharmacon SMARTpool library, Thermo Fisher Scientific,
Lafayette, CO) in the MDA-MB-231, MDA-MB-468, SKOV3,
and OVCAR3 cell lines. Each pool of synthetic siRNAs was
arrayed in 96-well format, and transfections were performed in
triplicate plates using 25 nM of siRNA delivered by Dharma-
FECT I (Dharmacon). Six replicates of RISC-free non-targeting
siRNA and siRNA against PLK (toxic control) in each plate
provided negative and positive controls for cell death across the
entire screen, respectively. Briefly, DharmaFECT I was applied at
0.15 ml/well for 25 nM siRNA delivery in a reverse transfection
mode. After three days, the cell viability was assayed with a Cell
Titer Blue Cell Viability Assay (Promega, Madison, WI). Cell Titer
Blue reagent (resazurin 5 ml/well) was included in the last 3 h
incubation. Viable cells reduce resazurin into resorufin, which is
highly fluorescent. The fluorescence intensity was measured using
a microplate reader at an excitation wavelength of 530 nm and an
emission wavelength of 604 nm. Interplate bias was eliminated by
normalizing cell viability values by mean centering and scaled to
have equal variance and then converted to the corresponding z-
scores for each of the three replicate experiments. The z-score of
gene ‘i’ for replicate ‘j’ in plate ‘k’ was calculated as zij =( xij – mjk)/
sjk, where, xij is the raw intensity value, and mjk and sjk are the
mean and standard deviation of intensities for all samples in plate
k, respectively. Next, the median z-score was calculated over all
replicates of each gene in each cell line, and siRNAs with zi
ave
values lower than -2 were considered as significantly inhibitory
‘‘hits’’ for the corresponding cell line.
Transfection and siRNA Reagents
siRNAs (Dharmacon; Thermo Fisher Scientific, Lafayette, CO)
were transfected with DharmaFECT I (Dharmacon) or Lipofecta-
mine RNAiMAX (Invitrogen) using the manufacturers’ protocols.
The sequences of the siRNAs are as follows: control RISC-free
nontargeting siRNA (D-001220-01-05), COPA (L-011835-00),
COPB1 (L-017940-01), COPB2 (L-019847-00), COPG1 (L-
019138-00), COPG2 (L-019988-01), COPD (L-013063-01),
COPE (L-017632-01), COPZ1 (L-020293-01), PLK1 (M-
003290-01), BiP1 (L-008198-00-0005), Atg5 (L-004374-00), and
Atg12 (L-010212-00).
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Cell samples were fixed with a solution containing 3%
glutaraldehyde plus 2% paraformaldehyde in 0.1 M cacodylate
buffer, pH 7.3, for 1 h. After fixation, the samples were washed
and treated with 0.1% Millipore-filtered cacodylate buffered
tannic acid, postfixed with 1% buffered osmium tetroxide for
30 min, and stained en bloc with 1% Millipore-filtered uranyl
acetate. The samples were dehydrated in increasing concentra-
tions of ethanol, infiltrated, and embedded in LX-112 medium.
The samples were polymerized in a 70uC oven for 2 days.
Ultrathin sections were cut in a Leica Ultracut microtome (Leica,
Deerfield, IL), stained with uranyl acetate and lead citrate in a
Leica EM stainer, and examined in a JEM 1010 transmission
electron microscope (JEOL, USA, Inc., Peabody, MA) at an
accelerating voltage of 80 kV. Digital images were obtained using
an AMT Imaging System (Advanced Microscopy Techniques
Corp, Danvers, MA).
SDS-PAGE and Western Blot Analysis
Western blotting was performed as previously described [12].
The following antibodies were used: p62 (BD Biosciences, Franklin
Lakes, NJ), LC3 (Novus Biologicals, Littleton, CO), IRE1a, BiP,
calnexin, Atg5, Atg12, pSer473AKT, pThr308AKT, AKT,
pSer235/236 S6, pSer65 4EBP, and 4EBP (all from Cell Signaling
Technology, Beverly, MA), COPB1 (Fisher Scientific, Lafayette,
CO), and b-actin (Sigma-Aldrich). Antibodies against COPA,
COPB2, COPD, COPG1, and COPG2 were a kind gift from Dr.
Wieland (University of Heidelberg, Heidelberg, Germany).
Quantification of band intensity was performed by Un-Scan-It
gel software (version 5.1, Silk Scientific Corporation) and
expressed in terms of fold increase of control.
Confocal and Fluorescence Microscopy
Confocal microscopy. Immunostaining for LAMP2 (BD
Biosciences; 1/200) or COPB2 (1/1000) was performed using
standard procedures. For the tfLC3 assay, cells transiently
expressing tfLC3 [15] were grown overnight and treated as
described. Cells were fixed with 4% paraformaldehyde and stained
with 49-6-diamidino-2-phenylindole (DAPI). For Annexin-V-Alexa
568 staining, cells stably expressing GFP-LC3 were cultured in
eight well chamber slides (BD Biosciences) and treated as
indicated. Annexin-V-Alexa 568 (Roche, Mannheim, Germany)
staining was performed according to manufacturer’s instructions.
All images were taken on an Olympus FV1000 microscope with a
100X lens (N.A. 1.30). Images were acquired and processed using
the Fluoview software and ImageJ.
Fluorescence microscopy. Immunofluorescence images for
p62 (BD Biosciences; 1/200) were acquired using a Nikon Eclipse
TE200-E microscope and IPLab imaging software (BioVision
Technologies, Exton, PA).
Crystal Violet Cell Viability Assay
Viability assay (crystal violet) was performed using standard
procedures.
Clonogenic Replating Assay
Cells were grown under various conditions and all cells were
collected by trypsinization and were plated at 100–400 cells per
well in six-well tissue culture plates. Colonies were grown for 11–
14 days in complete growth medium and stained with 0.5% crystal
violet solution (80% dH2O, 20% methanol, 0.5% crystal violet).
Pictures of the colonies were taken using FluorChemE imaging
system (Cell Biosciences, Inc.), and the number of colonies was
analyzed using AlphaVIEW SA (version 3.2.3.0; Cell Biosciences,
Inc.). The experiment was performed in triplicate and repeated
two times.
RPPA Analysis
The RPPA procedures for antibody staining and signal
detection were performed as previously described [10,16].
Oncomine Data Base
The Bittner multicancer dataset is available in the public
domain at http://www.oncomine.org/main/index.jsp [17], and
therefore no IRB approval was required. Tissues with differential
expression of COPI complex members (P#10
26) were selected.
Statistics and Data Analysis
All data were analyzed using the GraphPad Prism 5 software
(GraphPad Software, Inc., San Diego, CA, USA). Comparisons
between the two groups were statistically evaluated by a two-tailed
paired t-test. A p-value of less than 0.05 was considered statistically
significant. To compare the gene expression levels in benign and
cancer groups, a two-sample Student’s t-test was used. We used
the Cox proportional hazard regression model for univariate
survival analysis. Cutoffs of the high and low expression groups
were optimized to achieve the lowest p-value. All statistical
analyses, box plots, and Kaplan-Meier survival plots were
performed using R Software (http://www.r-project.org).
Results
siRNA Screening Identifies Coatomer Complex Members
as Modulators of Viability and Autophagy
To identify novel molecular players in the control of autophagic
cell death, we performed two types of RNA interference (RNAi)
screens to find genes that when knocked down resulted in both
decreased cell viability and formation of autophagosomes. We first
screened the human kinome because kinases and kinase-related
genes are key regulators of complex cellular functions such as
autophagy. siRNAs were transfected in four different cell lines: two
ovarian cancer cell lines (SKOV3 [HER2 amplified; CDKN2A,
PIK3CA, and TP53 mutants] and OVCAR3 [PIK3R1 and TP53
mutants]) and two breast cancer cell lines (MDA-MB-231 [BRAF,
CDKN2A, KRAS, and TP53 mutants] and MDA-MB-468 [EGFR
amplified; PTEN, RB1, TP53, and SMAD4 mutants]) with different
genetic backgrounds. In total, we identified 67 genes, 9% of the
kinome, that when knocked down significantly reduced cell
viability (z-score less than -2) (Table S1). Of these 67 positive
hits, knockdown of 12 genes reduced the viability of at least two of
the cell lines tested. These genes were AKT2, CHEK1, COPB2,
PRKAR2B, RPS6KA2 and WEE1 (in three out of four cell lines) and
AVPR1B, CNKSR1, DGUOK, INSRR, JAK2, TAF1L (in two out of
four cell lines).
To identify genes also involved in the regulation of autophagy in
cancer cells, we conducted an image-based small RNAi library
(Accell; Table S2) screen with autophagosome formation as an
endpoint. MDA-MB-231, SKOV3, and U2OS cancer cell lines
were stably transfected with the green fluorescent protein–
microtubule associated protein 1 light chain 3 (GFP-LC3) reporter
vector [18,19]. Because LC3 is degraded during the final stages of
productive autophagy [20], the persistent accumulation of LC3 in
punctate vesicles was used as a marker for impaired or abortive
autophagy. Rapamycin, 2-deoxy-D-glucose (2DG), and imatinib
were positive controls for autophagosome formation. Non-
targeting scrambled siRNAs, used as negative controls, did not
result in autophagy (Fig. S1A–C). In all cell lines tested, we
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beta 1 (COPB1) caused an accumulation of the LC3-positive
speckles that are suggestive of autophagy (Fig. S1A–C; Table S3),
indicating that the autophagy mechanism is conserved among
different tumor lineages. In conclusion, using siRNA screens we
identified COPB2 and COPB1 as modulators of respectively cell
viability and autophagy.
Coatomer Proteins Modulate Cell Viability
COPB1 and COPB2, components of the COPI complex, were
considered as attractive candidates for further study based on the
significant impact in cancer cells on both cell viability and
autophagosome formation (Table S1 and S3, Fig. S1). In a
secondary screen, we validated and analyzed the effects on cell
growth and autophagosome formation after knocking down
independent members of this complex in three cancer cell lines
(MDA-MB-231, MDA-MB-468 and SKOV3). As shown in Figure
S2, siRNAs reduced expression of several COPI components.
Consistent with our findings from the siRNA screen, depletion of
COPA, COPB1, COPB2, COPG1, COPD, and COPZ1 reduced
cell growth (Fig. 1A and C). In contrast, cell viability was
unaffected in cells treated with non-targeting siRNA (Fig. 1A and
B) or only modestly affected in MCF10A, a normal-like breast cell
line, after COPB2 knockdown (Fig. S9B). Adding the pan-caspase
inhibitor zVAD did not rescue cell death (data not shown)
indicating that cell death was caspase-independent. To confirm
that cancer cells are committed to death when COPI is impaired,
we determined clonogenic recovery after 72 h of siRNA treatment
in MDA-MB-231 (Fig. 1D) and U2OS (Fig. 1E) cancer cells. In
both cell lines, replating efficiencies were not reduced after
COPG2 depletion compared to control, confirming our results. In
contrast, reducing expression of COPA or COPB2 almost
completely abolished clonogenic recovery (Fig. 1D and E), which
is consistent with our viability results (Fig. 1A). Notably, replating
efficiency was not reduced in U2OS cells treated with rapamycin
(Fig. 1F), consistent with the ability of rapamycin to induce
productive autophagy as a survival process. Cell death after COPI
knockdown was further visualized and confirmed using Annexin V
staining (Fig. S3). Altogether, these results show that most COPI
components modulate viability of cancer cells.
Coatomer Proteins Modulate Autophagy
Next, we tested whether depletion of different independent
COPI complex proteins initiated autophagy, using punctate GFP-
LC3 formation as a readout. Reduced expression of COPA,
COPB1, COPB2, COPG1, COPD, and COPZ1 induced the
punctate GFP-LC3 formation in MDA-MB-231, MDA-MB-468
and SKOV3 cancer cell lines (Fig. 2A). These results were
comparable to those seen when cells were treated with imatinib, a
positive control for autophagosome induction (Fig. 2A–C).
Autophagosome formation was also assessed by the conversion
of endogenous LC3-I to LC3-II using immunoblotting because the
amount of LC3-II correlates with the amount of autophagic
membranes labeled with LC3-II [19]. Consistent with the data
obtained in cancer cells exogenously overexpressing GFP-LC3
(Fig. 2A–C) and with the exception of COPG2, reducing the
expression of the coatomer subunits led to an accumulation of
endogenous LC3-II in MDA-MB-231 cells (Fig. 2D). Similar
results were found in MDA-MB-468 and U2OS cancer cells
(Fig. 2E). We further validated the persistence of the LC3-II
increase after COPI depletion by an extended time course analysis
(Fig. 2F). A sustained reduced expression of COPI maintained
LC3-II expression without apparent degradation of LC3-II,
suggestive of impaired autophagy. Electron microscopy analysis
(Fig. 3A, C and E; inserts Fig. 3B, D and F) confirmed the
formation and marked increase (Fig. 3G) of autophagosomes after
COPB2 depletion (Fig. 3C and D) and imatinib treatment (Fig. 3E
and F) at the ultrastructural level by the presence of double
membrane organelles containing undigested cytoplasmic contents
[18]. In contrast, control siRNA (RF) (Fig. 3A and B) did not
promote autophagosome formation. Although the increase in
autophagosomes was similar between MDA-MB-231 cells treated
with COPB2 siRNA and imatinib, we found that autophagosomes
induced by COPB2 siRNA were significantly larger compared to
autophagosomes induced by imatinib as assessed by quantification
of the autophagosomal/cytoplasm area on electron microscopy
pictures (Fig. 3H). This observation was further confirmed by
determination of the size of GFP-LC3 positive organelles of MDA-
MB-231 cells treated with COPB2 siRNA or control siRNA (Fig.
S4A). The size of autophagosomes induced by siCOPB2 is also
larger than that of starvation-induced autophagosomes (Fig. S4B
and S4C). Collectively, these results indicate that COPI depletion
results in accumulation of LC3-positive speckles in cancer cells.
Disruption of COPI Induces Abortive Autophagy
Because depletion of COPI complex members caused cell death
and autophagosome formation, we set out to test whether abortive
autophagy was the mechanism. To differentiate between abortive
and productive autophagy we analyzed p62, which is preferentially
degraded during autophagy, but levels remain constant or
increased upon the induction of abortive autophagy [21]. As
determined by immunoblot analysis of different cancer cell lines
(Fig. 4A) and immunofluorescence analysis in MDA-MB-231 cells
(Fig. 4B,C), siCOPB2 did not reduce p62 levels, as would be
expected of productive autophagy, but increased the levels of p62
as compared to the control levels. In contrast, p62 levels were
decreased in MCF10A (Fig. S9D), although COPB2 protein levels
were significantly decreased (Fig. S9C). In addition, we used
Bafilomycin A1 (BafA1), a lysosome-specific inhibitor of protein
degradation and the end stages of the autophagy process to inhibit
autophagic flux [18,22]. BafA1 treatment has been shown to
increase LC3-II levels in cells undergoing productive autophagy
but has limited effect on LC3-II levels in cells undergoing abortive
autophagy [20]. In MDA-MB-231 cells with knockdown of
COPB2, BafA1 treatment did not further increase the LC3-II
levels (Fig. 4D) in contrast to COPG2 depleted or control cells,
indicating impaired degradation of the autophagosomal content
by the lysosomes after COPB2 depletion. We confirmed this
observation in U2OS cancer cells treated with either BafA1 or
rapamycin (Fig. S5). Impaired degradation of the inner luminal
content of autophagosomes by lysosomes can result from: 1) failed
autophagosome/lysosome fusion; 2) impaired degradation; or 3)
incomplete recycling of the autolysosomal components [18,23]. To
determine which of these possibilities was responsible for the
increase in LC3-II and p62 in cells with COPI depletion, we first
analyzed fusion of autophagosomes (GFP-LC3) and lysosomes
(LAMP2) after knockdown of COPI in MDA-MB-231 cells stably
transfected with GFP-LC3 (Fig. 5A). Confocal analysis revealed
colocalization of GFP-LC3 and LAMP2 in cancer cells treated
with siRNA against COPB2 (Fig. 5A), suggesting fusion was not
completely blocked by depletion of COPI. We further tested the
effect of COPB2 siRNA on autophagosomal degradation using
mRFP-GFP tandem fluorescent tagged LC3 (tfLC3; [15]). In cells
transiently transfected with tfLC3, GFP2/RFP-positive puncta
represent autophagosomes not fused to lysosomes, whereas RFP-
positive/GFP-negative puncta represent autolysosomes as GFP is
more rapidly quenched by low lysosomal pH [15]. MDA-MB-231
cells transiently transfected with tfLC3 showed colocalization of
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treatment (Fig. 5B, row 2 and 3), indicative of impaired
maturation of the autophagosomes. Treatment of MDA-MB-231
cells with imatinib resulted in RFP-positive/GFP-negative puncta
representing the presence of autolysosomes and thus autophagic
flux (Fig. 5B, last row). Similar results were obtained in U2OS
cancer cells (Fig. S6). In addition, COPB2 depleted cells showed
large LAMP2 positive organelles (Fig. S4D). Together, these
results indicate that disruption of COPI induces impaired, abortive
autophagy possibly through a failure in the maturation and
recycling process.
Abortive Autophagy Induces Endoplasmic Reticulum
Stress
Coatomer proteins are known to function as carriers between
the endoplasmic reticulum (ER) and the Golgi apparatus to return
essential proteins to the ER [24]. Therefore, we hypothesized that
knockdown of COPI complex proteins would promote ER stress
and an unfolded protein response (UPR). Although the UPR is
generally viewed as a cytoprotective response, similar to autoph-
agy, prolonged ER stress has been proposed to provoke cell death
through different pathways [25]. Compatible with induction of ER
stress and activation of UPR, knockdown of independent members
of COPI increased calnexin, BiP, and IRE1a levels in MDA-MB-
231 cells (Fig. 6A). Ultrastructural analysis (Fig. 6B–E) further
confirmed the presence of ER stress. As compared to filament-like
ER structures seen in control cells (Fig. 6B) or after imatinib
treatment (Fig. 6D), knockdown of COPB2 (Fig. 6C) or BafA1
treatment (Fig. 6E) promoted swelling of ER, a pathognomonic
sign of ER stress [26]. ER stress induced by depletion of COPB2
was also observed in U2OS cells (Fig. 6F).
To investigate whether a link exists between ER stress and
autophagy, we investigated siRNA-mediated knockdown of BiP,
which inhibits most signaling pathways of the UPR [27].
Reduction of ER stress by BiP knockdown slightly decreased
LC3-II levels, but not p62 levels, caused by knockdown of COPB2
(Fig. 6G). However, BiP knockdown blocked ER stress caused by
Figure 1. Coatomer proteins modulate cell viability. (A) MDA-MB-231, MDA-MB-468, and SKOV3 cells were transfected with siRNA targeting
independent members of COPI. Knockdown of PLK1 was used as positive control for cell death. Cell number after 72 h was measured by crystal violet
staining. (B,C) Representative light microscopy pictures of MDA-MB-231 cells treated with RF or siRNA against COPB2. (D) Clonogenic replating
efficiency of MDA-MB-231 breast cancer cells after decreased expression of COPA, COPB2 or COPG2 compared to cells treated with risc-free (RF).
Results are the mean 6 SD from triplicates of two independent experiments. Clonogenic replating efficiency of U2OS cancer cells after treatment
with siRNA against COPB2 or COPG2 (E) or rapamycin (F). Results are the mean 6 SD from triplicates of two independent experiments. **, p,0.01; ***,
p,0.001.
doi:10.1371/journal.pone.0039400.g001
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39400Figure 2. Coatomer proteins modulate autophagy. (A) MDA-MB-231, MDA-MB-468, and SKOV3 cells stably overexpressing GFP-LC3 were
transfected with siRNA targeting independent members of COPI for 72 h, and autophagosome formation was analyzed using the IN Cell analyzer
1000 system. Imatinib was used as a positive control for autophagosome formation. Results are the mean 6 SD from triplicates. Representative graph
of two independent experiments is shown. (B,C) Representative epifluorescent microscopy images (IN Cell Analyzer 1000) of GFP-LC3–positive
vesicles in control MDA-MB-231 cells or after COPB2 depletion. (D) Immunoblot analysis of LC3 in MDA-MB-231 cells 72 h after siRNA mediated
depletion of independent members of COPI. b-actin was used as a loading control. (E) MDA-MB-468 and U2OS cells treated with RF or COPB2 siRNA
were assayed for protein levels of LC3. (F) MDA-MB-231 cells were transfected with siRNA against COPB2, COPG2 or risc-free (RF) and grown for the
indicated times, lysed, and immunoblotted with antibodies to LC3, COPB2, COPG2 and b-actin. *, aspecific band.
doi:10.1371/journal.pone.0039400.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39400brefeldin A (BFA), but we could not detect changes in LC3-II or
p62 (Fig. 6G). BFA, an ER stress inducer was used as a positive
control not only because it induces the UPR, but also because it
inhibits the budding of non-clathrin coated vesicles from the Golgi,
effects which are similar to those seen when the COPI complex is
depleted [28]. These results suggest that abortive autophagy
induced by disrupting the COPI complex is upstream of ER stress.
In addition, we found that inhibition of autophagy initiation by
Figure 3. COPI depletion increases autophagosome formation. (A–F) Transmission electron microscopy analysis of autophagy in MDA-MB-
231 cells treated with RF or siRNA against COPB2 for 48 h or imatinib for 24 h. White arrowheads indicating autophagosomes are shown in panels C
and E. (B, D, F) High magnification images of boxed areas. Scale bars indicate 2 mm (A, C, E) and 500 nm (B, D, F). (G) Number of autophagosomes per
cell was calculated by counting the number of double membrane organelles in 20 or more individual cells. (H) Percentage autophagosomal area was
calculated by measuring area covered by double membrane organelles in the cytoplasm of 20 or more individual cells. **, p,0.01; ****, p,0.0001,
doi:10.1371/journal.pone.0039400.g003
Figure 4. COPI depletion induces abortive autophagy. (A) Indicated cancer cell lines were treated with control siRNA (RF) or COPB2 siRNA for
72 h and p62 level was analyzed by immunoblotting. Quantification of p62 protein levels is shown as the mean 6 SD from four independent
experiments. **, p,0.01. (B,C) MDA-MB-231 cells were treated as in (A) and p62 was analyzed by immunofluorescence microscopy. (D) COPB2 or
COPG2 depleted MDA-MB-231 cells were analyzed for LC3 accumulation in the absence or presence of 50 nM BafA1.
doi:10.1371/journal.pone.0039400.g004
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39400depleting ATG5/12 suppressed the COPB2-induced increase in
ER stress, as seen by suppression of BiP upregulation (Fig. 6H).
Depletion of ATG5/12 also reversed the elevated p62 levels
induced by COPB2 siRNA, suggesting that the early stages of
autophagy were inhibited (Fig. 6H). Moreover, BafA1 increased
BiP and IRE1a protein expression levels in control cells or after
COPG2 depletion (Fig. 6I). These data indicate that abortive
autophagy provoked by COPI depletion acts upstream of ER
stress and that abortive autophagy is sufficient to induce ER stress.
Abortive Autophagy Decreases PI3K/AKT Signaling
To elucidate the mechanisms underlying abortive autophagy
generated by COPB2 depletion, we employed a functional
proteomic approach, reverse phase protein array (RPPA) to
identify signaling molecules that are changed after COPB2
depletion [16,29]. We quantitatively analyzed the expression
profiles of 160 proteins in MDA-MB-231 breast cancer cells 48 or
72 hours post-infection with non-targeting control siRNA or
siRNA targeting COPB2 or COPG2. To identify the effect on
downstream signaling exclusively associated with COPB2 deple-
tion, we tested for significant differences (p,0.05) between cells
treated with siRNA against COPB2 compared to cells treated with
non-targeting or COPG2 siRNA. Figure 7A shows the heatmap of
59 proteins whose expression is altered specifically and signifi-
cantly by COPB2 siRNA. We can distinguish three different
groups of protein expression patterns: gradually upregulated,
transient expression or downregulated. The RPPA results showed
that impaired autophagy induced by siCOPB2 was accompanied
by a significant decrease in multiple components of the PI3K/
AKT signaling pathway (e.g. pS473AKT, pS65 4EBP, cyclin D1,
pY452GAB2) (Fig. 7A). The changes in phospho-AKT expression
levels and downstream targets were validated and confirmed by
western blot analysis in MDA-MB-231, MDA-MB-468 and U2OS
cancer cell lines (Fig. 7B–C). In agreement with these results,
chemical induction of abortive autophagy by BafA1 decreased
AKT signaling in a panel of breast cancer cell lines (Fig. S7). These
results suggest that COPI regulates PI3K/AKT signaling.
COPI Proteins are Overexpressed in Cancer Cell Lines and
Implicated in Cancer Pathophysiology
Although the role of the COPI complex in trafficking between
the ER and Golgi apparatus during recycling and cisternal
maturation [30,31] has been extensively investigated, little is
known about the expression and function of the different members
of the COPI complex in cancer. In addition, their role in
productive autophagy makes them potential oncogenes. To
investigate the expression pattern of COPI complex subunits, we
analyzed mRNA levels in tissues from 14 different types of cancers
using Oncomine. COPI members showed aberrant expression in 6
out of 14 cancer types in the Bittner multicancer dataset
(GSE2109; Table 1). These data were independently validated
by examination of datasets that compare benign ovarian samples
to ovarian cancer samples (Fig. 8A, [32]; Fig. S8, [33]) and
different subtypes of breast cancer (Fig. 8B, [34]). High levels of
COPB2 correlated with significantly lower survival rates in breast
cancer patients (Fig. 8C, [35]). We also detected higher protein
levels of COPI components in an array of breast cancer cell lines
compared to MCF10A, a non-transformed mammary epithelial
line (Fig. S9A).
Discussion
In this study, we found that members of COPI are critical
inhibitors of productive autophagy and cell death in cancer cells.
Indeed, depletion of COPB2 was found to induce abortive
autophagy or autophagic cell death, which occurred before ER
stress and cell death (Fig. 9). In addition, disruption of the COPI
complex affected multiple signaling pathways involved in cancer
cell survival, most importantly AKT signaling pathway. Moreover,
different tumor lineages show higher expression levels of COPI
members compared to normal tissue which correlated with worse
patient outcome.
COPI is a heptameric coat complex consisting of two
subcomplexes, F (COPB1, COPG, COPD, and COPZ) and B
(COPA, COPB2, and COPE), which are both required for the
binding of membrane proteins [36]. COPI functions in the
retrograde transport of luminal and membrane proteins in the ER-
Golgi segment of the secretory pathway, by bringing escaped ER
resident proteins back to the ER [37] and in the transport of cargo
from the Golgi apparatus [38]. The COPI subunits are recruited
to the Golgi and assemble into the COPI vesicle coat by activated,
GTP-bound Arf proteins [39]. COPI can also function as a
transporter of ER proteins independent of the Golgi [40]. More
recently, endosomal coatomer also has been shown to be required
for completion of the autophagic process [41]. Indeed, although
the COPI complex is not essential for autophagosome formation
[42], it plays an important role in the later stages of the autophagic
process [41]. All these shared functions between the COP
members suggest that depletion of any single member should
have, to some extent, the same functional effect. Our data show
that depletion of most, but not all (e.g. COPG2), of the COPI
subunits results in cell death and an increase in LC3-II positive
organelles in different cancer cell lines, pointing to the possibility
that the COPI complex might exist in different configurations for
its diverse set of functions [43–45]. Alternatively, some members of
the complex may be less critical for the correct functioning of the
COPI complex, perhaps because particular COPI complex
members have redundant functions. The essential role of the
COP proteins in our studies is in agreement with results found in
yeast; with the exception of COPE, yeast COP components are
strictly required for viability and inter-compartmental trafficking
[46–48].
COPB2, first identified as a receptor for activated C-kinase, was
found to increase LC3 levels in an siRNA screen for modulators of
autophagy [49]. Induction of autophagosomes can result from
increased autophagic flux or impaired clearance of the autophagic
content [20]. Several lines of evidence in our data led us to
hypothesize that the marked increase in autophagosomes and
sustained accumulation of LC3-II upon COPI depletion is the
result of an impaired autophagic pathway. First, knockdown of
COPI members stabilized or allowed the accumulation of p62 in
multiple cancer cell lines. Second, inhibition of autophagic flux
using a chemical inhibitor together with COPB2 knockdown did
Figure 5. COPI depletion inhibits complete degradation of autophagosomes. (A) GFP-LC3-expressing MDA-MB-231 cells were transfected
with risc free (RF) control or with siRNA against COPB2 for 72 h, processed to assess the colocalization between GFP-LC3 and LAMP2 by confocal
microscopy. Arrow, colocalization of GFP-LC3 and LAMP2. (B) tfLC3-expressing MDA-MB-231 cells were treated with control siRNA (RF) or COPB2
siRNA for 72 h and BafA1 (50 nM) or imatinib (10 mM) for 24 h. Colocalization of GFP and mRFP was assessed by confocal microscopy. Arrow, RFP-
positive/GFP-positive puncta (autophagosome); arrow with open arrowhead: RFP-positive/GFP-negative puncta (autolysosome). Scale bar first
column: 50 mM; scale bar last column: 25 mM.
doi:10.1371/journal.pone.0039400.g005
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colocalization experiments with tfLC3 revealed defective auto-
lysosome maturation. Finally, recycling of core components critical
for the autolysosomes appears to be impaired. These results
suggest that depletion of COPI members efficiently promotes
abortive autophagy. Our data are consistent with two previous
Figure 6. Loss of coatomer subunits promotes ER stress and activates UPR. (A) Independent COPI subunits were depleted in MDA-MB-231
cells and levels of calnexin, BiP, and Ire1a were measured by westernblot after 72 h. *, a non-specific band. (B–E) Transmission electron microscopy
analysis of MDA-MB-231 cells after 48 h treatment with non-targeting siRNA (RF) (B), siCOPB2 (C) or overnight treatment with imatinib (10 mM) (D) or
BafA1 (50 nM) (E). Electron micrograph showing the dilated ER (white arrow heads in C and E). M: mitochondria, N: nucleus and G: Golgi apparatus. (F)
COPB2 or COPG2 depleted U2OS cells were analyzed for BiP levels. (G) LC3, p62 and BiP levels were analyzed by immunoblot after depletion of
COPB2 and BFA treatment with or without BiP siRNA. (H) MDA-MB-231 cells were incubated with control siRNA or COPB2 siRNA, either alone or in
combination with siRNA targeting the Atg5/Atg12 complex. Images from different parts of one gel were grouped. (I) MDA-MB-231 cancer cells were
depleted of COPB2 or COPG2, either alone or with BafA1, and Ire1a and BiP levels were analyzed by immunoblot. BFA was used as a positive control
for ER stress.
doi:10.1371/journal.pone.0039400.g006
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PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e39400reports [41,50], both showing that knockdown of COPB2 leads to
the accumulation of autophagosomes owing to decreased lyso-
somal processing. Our results together with these of previous
studies show that most, but not all, COP subunits are required for
completion of the autophagic process. Remarkably, depletion of
COPB2 generated doughnut-like shapes, which are LAMP2-
positive, suggesting that while autophagosomes still fuse with
lysosomes, the lysosomal dissociation is impaired. Another
possibility is that the COPI proteins are required for the pH
changes needed for the degradation of the autophagosomal
content, which would be in agreement with the observation that
COPB1 is involved in the pH-dependent formation of transport
vesicles [51].
Since COPI proteins are involved in cargo-regulating transport
between the Golgi and ER, depletion of this complex may result in
the accumulation of proteins in the ER, leading to ER stress
accompanied by activation of the UPR. Although the UPR is
generally viewed as a cytoprotective response to protect the ER
and to limit cellular damage by the accumulation of unfolded or
misfolded proteins, prolonged ER stress can result in cell death
[25], similar to prolonged or non-productive autophagy. Indeed,
disturbance of ER homeostasis that cannot be rescued by the UPR
results in autophagy and cell death. In the case of COPI depletion,
however, we found that abortive autophagy (either by chemical
inhibition or by siCOPB2) preceded ER stress and is required for
the induction of ER stress. Although several reports have proposed
that autophagy is downstream of ER stress [52], our results
together with another report [53] suggest that autophagy may
regulate the UPR pathway and cause ER stress. Targeting cellular
components to aggravate ER stress could be a therapeutically
attractive strategy, because ER stress is modestly activated in many
cancers, particularly breast cancer, compared with normal tissue
[54,55]. This type of therapeutic targeting might be applied in
both apoptosis-resistant and apoptosis-sensitive cancer cells.
Indeed, this idea is supported by our findings in MDA-MB-231
breast cancer cells, which are competent to undergo apoptosis and
do undergo death through abortive autophagy upon COPI
depletion. Until now it was unclear whether cancer cells with
intact apoptotic machinery would enter autophagy as a death
mechanism. Although our data emphasize a unique role for COPI
in the induction of ER stress, this observation is in contrast with
previous results [41] showing a lack of ER stress after COPI
depletion. The differences may result from the use of cancer cells
instead of normal cells to investigate ER stress. Indeed, we used
cancer cell lines, which have higher levels of basal ER stress and
thus are more prone to the further elevation of ER stress to levels
inducing cell death. Further, many cancer cell lines have defects in
the apoptotic pathway potentially allowing autophagic and ER
stress induced cell death to be manifest. This sensitivity of cancer
cell lines to ER stress may further be exploited as a therapeutic
approach. The COPI complex may fine tune the delicate balance
of ER stress in cancer cells and may therefore explain the higher
levels the COPI complex members in cancer cells and tissues than
in normal cells.
While the function of COPI in cellular trafficking is well
established, its effect on downstream signaling is not fully
elucidated. A protein array performed on cells with downregula-
tion of COPB2 at different time points revealed an effect of COPI
on mTOR function, as analyzed by phosphorylation of its
downstream effector 4-EBP. Indeed, a potential important role
for COPI in TORC1 regulation is supported by a recent study
showing COPI as a key regulator of the mTORC1-S6K signaling
pathway [56]. In addition, intracellular trafficking by Rabs and
Arf GTPases has been shown to be important for mTORC1
Figure 7. RPPA analysis identifies signaling pathways altered during abortive autophagy. (A) RPPA analysis was performed on lysates of
MDA-MB-231 cells depleted from COPB2 for 48 h or 72 h. The heatmap represents values of triplicates normalized to a pool of controls
(untransfected, mock transfected and RF transfected cells). Significant changes in proteins related to depletion of COPG2 were excluded. (B,C)
Phosphorylated and total levels of the indicated proteins were validated in MDA-MB-231, MDA-MB-468 and U2OS cells. Actin was used as a loading
control. M: marker.
doi:10.1371/journal.pone.0039400.g007
Table 1. COPs are overexpressed and implicated in the pathophysiology of a number of cancer lineages.
Tumor Type COPA COPB1 COPB2 COPG1 COPG2 COPD COPE COPZ1 COPZ2
Bladder 10
27
Pancreatic
Cervical
Breast 10
211 10
29 10
29 10
220
Liver
HN
Lymphoma
Prostate 10
29 10
27 10
26
Sarcoma 10
211
Lung
Brain, CNS
Colorectal 10
217 10
210 10
28 10
213
Ovarian 10
28 10
215
Kidney
Aberrations with P#10
–6 are indicated. Data are derived from a reanalysis of Bittner Multicancer Dataset (www.oncomine.org). HN, Head and Neck; CNS, Central Nervous
System.
doi:10.1371/journal.pone.0039400.t001
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tion of mTORC1 [57].
Although much information is available about the function of
the COPI complex, its relevance to cancer has been under-
explored. To better understand its role in cancer, we analyzed
several publicly available databases and found that COP proteins
are frequently overexpressed in different types of cancer. Our
results indeed show that high expression of COPI proteins
correlated with a lower survival rate, indicating a role for COPI
in cancer. In addition, COPI subunits were also higher expressed
in a set of breast cancer cell lines compared to a MCF10A, a non-
transformed breast cell line. In contrast to MDA-MB-231 breast
cancer cells in which COPB2 depletion induced cell death,
abortive autophagy and ER stress, COPB2 knock down in
MCF10A cells had modest effect on viability, induced autophagic
flux and did not increase ER stress (Fig, S9B–D), indicating a
therapeutic opportunity if inhibitors targeting one or more of the
components of COPI can be developed. Indeed, both autophagy
and ER stress responses represent adaptive mechanisms for the
survival of cancer cells [27]. Aggravating those processes by e.g.
decreasing the expression of COPI, may convert their protective
effect into a cell death mechanism. Recently, COPA emerged as a
target in mesothelioma [58], therefore identifying COP proteins as
potential therapeutic targets for cancer. A meta-analysis also
identified COPB2 as one of four downstream targets of PKCi
[59], which we have shown to contribute to poor prognosis
through loss of apical-basal polarity and overexpression of cyclin E
in ovarian cancer [60]. Whether COP proteins are associated with
a worse outcome for cancer patients due to their effects on cell
polarity or on autophagy modulation, is a subject for future
investigation.
Figure 8. COPI members are overexpressed in cancer. Expression level of COPB2 in (A) ovarian cancer tissue compared with benign tissue and
(B) different subtypes of breast cancer. (C) Survival fraction related to high or low COPB2 levels. The cutoff for high and low COPB2 expression is 9.58
(RMA preprocessed log value); this cutoff is optimized to achieve the lowest p value. RMA, Robust Multi-array Average.
doi:10.1371/journal.pone.0039400.g008
Figure 9. Schematic representation of the role of COPI in the regulation of productive and abortive autophagy. COPI is required for
productive autophagy under basal conditions. Depletion of the COPI complex results in abortive autophagy, ER stress and decreased PI3K/AKT
signaling.
doi:10.1371/journal.pone.0039400.g009
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e39400In summary, targeting productive autophagy in cancer cells and
converting the process into a cell death mechanism is a promising
therapeutic avenue, particularly for cancer cells in which apoptosis
is compromised. Further research is needed to validate whether
the induction of abortive autophagy will specifically target cancer
cells, without causing toxic effects on normal cells. Regardless,
here we have shown that targeting the COPI complex is a potent
mechanism to block productive autophagy and stimulate cell death
in cancer cells.
Supporting Information
Figure S1 Screen for modulators of autophagy in cancer
cells stably expressing GFP-LC3. The Accell library
targeting 71 genes was transfected in (A) MDA-MB-231, (B)
U2OS, and (C) SKOV3 cancer cells. Appropriate positive and
negative controls for the small library screen were used. GFP-LC3
punctate formation was analyzed with an IN Cell Analyzer 1000
Cellular Imaging and Analysis system. Genes were sorted based on
the percentage of cells with more than 10 punctate dots (%
autophagy).
(TIF)
Figure S2 Validation of efficient knockdown by siRNA
treatment. MDA-MB-231 breast cancer cells were incubated
with the indicated siRNAs for 72 h and analyzed for knockdown
of the corresponding protein. *, aspecific band.
(TIF)
Figure S3 Knockdown of COPB2 increases Annexin V-
positive MDA-MB-231 breast cancer cells. MDA-MB-231
cells were treated with siRNA against COPB2 and Annexin V
staining was compared to control cells transfected with risc free
(RF). Scale bar: 50 mM.
(TIF)
Figure S4 COPB2 depletion impairs autophagosomal
and lysosomal recycling. (A) GFP-LC3 transfected MDA-MB-
231 cells treated with the indicated siRNAs were assessed for
organelle mean area using the IN Cell Analyzer 1000 Cellular
Imaging and Analysis system. Results shown are mean 6 SD
triplicates of two independent experiments. ***, p,0.001. (B,C)
Transmission electron microscopy analysis of MDA-MB-231 cells
after knockdown of COPB2 compared to cells starved from serum
and glucose (SF/GF). White arrowheads indicate autophago-
somes. Scale bar indicates 2 mm. (D) MDA-MB-231 cells
transfected with RF or siRNA targeting COPB2 were analyzed
by fluorescence microscopy for LAMP2 (green), COPB2 (red) and
nucleus (blue) 72 h post transfection.
(TIF)
Figure S5 COPB2 depletion blocks rapamycin-induced
autophagy. U2OS cancer cells were treated 48 h with COPB2
siRNA prior to rapamycin (rapa) treatment (100 nM, 24 h) or
BafA1 treatment (50 nM, 24 h). Lysates were analyzed for the
indicated proteins.
(TIF)
Figure S6 COPI depletion inhibits complete degrada-
tion of autophagosomes in U2OS cells. tfLC3-expressing
U2OS cells were treated with control siRNA (RF) or COPB2
siRNA for 72 h and BafA1 (50 nM) or rapamycin (100 nM) for
24 h. Colocalization of GFP and mRFP was assessed by confocal
microscopy. Arrow, RFP-positive/GFP-positive puncta (autopha-
gosome); arrow with open arrowhead: RFP-positive/GFP-negative
puncta (autolysosome). Scale bar first column: 50 mM; scale bar
last column: 25 mM.
(TIF)
Figure S7 Abortive autophagy induced by Bafilomycin
A1 decreases AKT activity in multiple breast cancer cell
lines. Indicated cell lines incubated for 24 h with BafA1 (50 nM)
were analyzed for expression levels of LC3, and total and
phosphorylated (pS473AKT, pT308AKT) AKT levels.
(TIF)
Figure S8 COPB2 is overexpressed in serous ovarian
cancer. COPB2 levels in serous cancer tissue compared with
benign tissue in the UCSF dataset.
(TIF)
Figure S9 Differential expression and function of COPI
in cancer cells versus normal cells. (A) Protein levels of
COPI members in different breast cancer cell lines were compared
to MCF10A. (B) Cell number of COPB2 depleted MCF10A cells
was compared with control cells (Ctr) or cells treated with
transfection reagent (mock) or non-targeting siRNA (RF) for 72 h.
Results shown are mean 6SD of four replicates. *, p,0.05. (C)
Validation of efficient knockdown of COPB2 in MCF10A cells
after 72 h of siRNA treatment. (D) Using western blot analysis,
MCF10A cells were analyzed for the indicated proteins after knock
down of COPB2 for 72 h.
(TIF)
Table S1 List of positive hits from the siRNA library
screening of the human kinome for modulators of
viability in cancer cell lines of different lineages.
(XLS)
Table S2 List of Accell siRNA pools used to screen for
autophagy modulators in cancer cell lines of different
lineages.
(XLS)
Table S3 List of z-scores from the Accell siRNA library
screening for modulators of autophagy in cancer cell
lines of different lineages.
(XLS)
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